Introduction
============

Cell cycle regulation is fundamental for normal development and homeostasis in multicellular organisms. Deregulation of cell cycle causes many severe diseases, such as developmental abnormalities and cancer. Cyclin-dependent kinases (CDKs) and CDK-inhibitory proteins (CKIs) positively and negatively control cell cycle progression as an accelerator and brake, respectively, that make it possible to tightly regulate the cell cycle. Many CDKs, including Cdk1, 2, and 4, are activated via binding to cyclins, whereas Cdk5 is mainly activated by p35 and p39 ([@B30]). CKIs are classified into cip/kip and ink4 families. The cip/kip family contains p21^cip1^, p27^kip1^, and p57^kip2^, whereas the ink4 family consists of p16^Ink4a^, p15^Ink4b^, p18^Ink4c^, and p19^Ink4d^ ([@B70]; [@B47]).

Like the other cip/kip proteins, p27^kip1^ (hereafter, p27) binds to a cyclin-CDK complex to suppress the kinase activity of CDKs in general, although p27 does not inhibit the Cyclin D-Cdk4 complex in proliferating cells, where the Cyclin D/Cdk4 enhances the phosphorylation of p27 at Tyr88, resulting in its degradation ([@B10]; [@B19]; [@B27]; [@B61]). Both cyclin- and CDK-binding domains of p27 are located in the N-terminal. A crystal structure of the N-terminal region of p27, cyclin A and Cdk2 shows that the 3~10~ helix (residues 85--90 in human) of p27 binds deep within the catalytic cleft of Cdk2 and occupies its ATP-binding site ([@B68]). This structural inhibition of the kinase activity of CDK requires strong binding between p27 and the cyclin-CDK complex, because mutations in the cyclin-binding region of p27 reduce the CDK inhibitory activity of p27 ([@B81]).

The protein levels of p27 are high in the G1 phase in proliferating cells. The stability of p27 protein is regulated by its phosphorylation. Phosphorylation at Thr187 or Ser10 promotes or suppresses a proteasome-dependent protein degradation of p27 in S/G2 or G0/G1 phases, respectively ([@B69]; [@B81]; [@B9]; [@B52]; [@B75]; [@B79]; [@B24]; [@B48]; [@B38]; [@B32]). While overexpression of wild-type p27 induces G1 arrest in cultured cells, p27 mutated in either cyclin- or CDK-binding region loses the ability to induce G1 arrest, indicating that p27-mediated inhibition of the cyclin-CDK complex suppresses the entry of S phase ([@B81]).

In the neural progenitor cells in the developing cerebral cortex, p27 controls the lengths of the G1 phase and cell cycle exit ([@B51]; [@B78]). In the postnatal and adult subventricular zones, which provide new neurons that migrate to the olfactory bulb, p27 negatively regulates neurogenesis ([@B14]; [@B42]).

Thus, many studies have indicated that p27 is essential for cell cycle regulation in proliferating cells, including neural progenitors. In addition to its cell cycle-related roles, accumulating evidence indicates that p27 has extra-cell cycle regulatory function (EXCERF) in growth-arrested cells ([@B34]). Here, we introduce the roles of p27 in cytoskeletal organization and cell migration and discuss its possible involvement in membrane trafficking pathways, with particularly focusing on immature neurons in the developing cerebral cortex.

EXCERF of Cytoplasmic p27 in Neuronal Migration
-----------------------------------------------

p27 is mainly localized in the nucleus to inhibit the activity of cyclin-CDK complexes and this nuclear p27 acts as a tumor suppressor ([@B7]; [@B66]). However, in breast cancer cells, p27 becomes relocalized in the cytoplasm in an Akt-mediated phosphorylation at Thr157-dependent manner, and appears to lose its tumor suppressive activity ([@B44]; [@B73]; [@B80]). Interestingly, many cancers, such as ovarian cancer and melanoma, show a correlation between cytoplasmic p27 and malignancy ([@B67]; [@B13]). In addition, cytoplasmic p27 promotes the migration of HepG2 hepatocarcinoma cells ([@B49]), suggesting that p27 has functionally significant roles outside of the nucleus.

In primary cortical neurons, p27 is mainly localized in the nucleus but also exhibits punctate localization in the cytoplasm ([@B32]). *In vivo*, some p27 is localized in the cytoplasm of the immature neurons in the developing cerebral cortex and postnatal subventricular zone ([@B32]; [@B42]). It has been reported that p27 promotes the migration of immature excitatory and inhibitory neurons in the developing cerebral cortex ([@B32]; [@B56]; [@B18]; [@B58], [@B57]; [Figure 1A](#F1){ref-type="fig"}). p27 regulates immature neurite formation in multipolar-shaped immature excitatory neurons ([@B32]) and neurite branching in immature inhibitory neurons ([@B18]). These effects on cell migration and morphological changes are at least in part dependent on cytoplasmic p27, because p27 is shown to regulate actin and microtubule organization to promote migration ([@B32]; [@B18]; [Figure 1A](#F1){ref-type="fig"}). Furthermore, a recent paper shows that p27 controls the acetylation of microtubules via stabilization of α-tubulin acetyltransferase 1 (ATAT1), which modulates axonal transport ([@B53]).

![Schematics depicting the roles of p27 in mitotic neural progenitors and post-mitotic neurons. **(A)** p27 controls G1 length and cell cycle exit in neural progenitors. In addition, p27 exhibits many extra-cell cycle regulatory function (EXCERF) in growth-arrested neurons. p27 promotes immature neurite formation, neuronal migration and axonal transport. p27 is also required for dendritic spine maturation and long-term memory in adult hippocampus. **(B)** p27 regulates actin reorganization through the suppression of RhoA and the activation of an actin-binding protein, cofilin. p27 also interacts with microtubules and ATAT1 to control microtubule organization and axonal transport, respectively. **(C)** In post-mitotic cells, cell cycle proteins select two different fates. In general, cell cycle-related proteins, such as cyclin A and PCNA, are suppressed after cell cycle exit and the re-activation of these proteins in growth arrested cells induces cell cycle events, which are priming events to cell death. In contrast, accumulating evidence indicate that other cell cycle-related proteins, including p27, p57, and cyclin E, maintain their expression levels after growth arrest. Growth arrest may switch on extra-cell cycle regulatory functions (EXCERFs) in these proteins.](fcell-07-00064-g001){#F1}

EXCERF of Nuclear p27 in Neuronal Differentiation and Migration
---------------------------------------------------------------

Nuclear p27 also participates in EXCERF, because p27 regulates transcription factors in neurons. p27 interacts with p300 and E2F4 and recruits histone deacetylases and mSIN3A to repress transcription of target genes ([@B64]). Furthermore, p27 is shown to regulate gene expression of cell adhesion molecules, including protocadherin-9 and Ncam1 ([@B6]). Thus, p27 is associated with various chromatin regions to control transcription.

In the developing cerebral cortex, p27 stabilizes Neurogenin2, a bHLH transcription factor, in cortical neural progenitors and promotes neuronal differentiation ([@B56]; [Figure 1A,B](#F1){ref-type="fig"}). It is also reported that p27 regulates neuronal migration as well as cell cycle exit in cooperation with Rp58, a transcriptional repressor ([@B11]), but it is unclear whether p27 interacts with Rp58. In the adult hippocampus, neural stem cells give rise to granule neurons of the dentate gyrus throughout life. While p27 is involved in the regulation of stem cell quiescence, this may not result from the EXCERF of p27 ([@B1]). The negative regulation of the hippocampal stem cell proliferation depends on the cyclin- and CDK-binding domain of p27. p27 suppresses the kinase activity of Cdk6, which promotes the expansion of hippocampal progenitors ([@B8]). However, it is unclear whether like in the developing cerebral cortex, p27 also promotes neurogenesis in the adult dentate gyrus through the regulation of transcription.

In differentiating chick retinal ganglion cells (RGCs), p27 is involved in the prevention of extra-DNA synthesis ([@B62]). The differentiating chick RGCs contain tetraploid cells. While the nuclei of some invertebrate neurons, including *Aplysia californica* giant neurons, contain 200,000-fold of the normal amount of haploid DNA, chick RGCs remain tetraploid (or diploid). This may be mediated by the EXCERF of p27, because knockdown of p27 promotes extra-DNA synthesis, which cannot be suppressed by Cdk4/6 inhibition ([@B62]).

Upstream Factors of p27
-----------------------

As described above, the protein stability of p27 is controlled by its phosphorylation. Cdk5 is an atypical CDK that is activated in post-mitotic neurons in a cyclin-independent manner, whereas Cdk2 binds to cyclin E and controls G1/S transition. Cdk5 is shown to directly phosphorylate p27 at Ser10, which protects it from proteasome-dependent protein degradation ([@B32]; [Figure 1B](#F1){ref-type="fig"}). In a Cdk5-deficient cerebral cortex, p27 protein levels are reduced in the cytoplasm and nucleus ([@B84]), suggesting that Cdk5 regulates the stability of both cytoplasmic and nuclear p27. Ser10 on p27 is also phosphorylated by other kinases, including Dyrk1A and Dyrk1B ([@B12]; [@B74]). Dyrk1A stabilizes p27 and induces cell cycle exit and neuronal differentiation in SH-SY5Y neuroblastoma cells, but the *in vivo* function of this Dyrk1A-mediated regulation of p27 is still unclear.

The Cdk5-p27 pathway plays roles in not only cortical neurons but also non-neuronal cultured cells, including migrating endothelial cells ([@B43]; [@B45]). However, p27 can also act upstream of Cdk5 in the cultured neurons treated with Aβ~1--42~ peptide that is a major cause of Alzheimer's disease. In brains with Alzheimer's disease, the expression of several cell cycle proteins is abnormally induced ([@B83]). In response to treatment with Aβ~1--42~ peptide, p27 promotes the formation of a Cdk5-Cyclin D1 complex that dissociates the Cdk5-p35 complex, resulting in neuronal cell death ([@B26]). It is consistent with previous reports revealing that the induction of Cyclin D1 in post-mitotic neurons leads to cell death ([@B23]; [@B36]), although its underlying mechanism is unclear because Cyclin D cannot activate Cdk5 ([@B41]). In contrast, the binding of p27 to Cdk5 in the nucleus has been reported to protect neurons from cell death via the suppression of cell cycle events ([@B84]). The disruption of the p27 and Cdk5 interaction in nuclei enhances the nuclear export of Cdk5, which deactivates the cell cycle events. Thus, Cdk5 and p27 have multiple functions in neurons and may activate several distinct downstream pathways that are associated with neuronal cell death.

Unlike Cdk5, Cdk2 phosphorylates p27 at Thr187 and the Thr187-phosphorylated p27 binds to Skp2, an E3 ubiquitin ligase, resulting in its degradation ([@B69]; [@B81]; [@B9]; [@B52]; [@B75]; [@B79]; [@B48]). Thus, Cdk5 and Cdk2 exert opposite effects on the protein stability of p27 through phosphorylation at distinct sites. Although Thr187 phosphorylation of p27 is observed in cortical neurons ([@B32]), it is unclear which kinase(s) contributes to this phosphorylation in post-mitotic neurons, where Cdk2 activity is low.

In addition to these kinases, it has been reported that connexin-43 (Cx43), a component of the gap junction, acts as an upstream regulator of p27. Knockdown of Cx43 reduces the protein levels of p27 in cortical neurons and disturbs the formation of immature neurites in cortical migrating neurons ([@B46]). Consistently, suppression of Cx43 expression perturbs the neuronal positioning in the developing cerebral cortex ([@B15]; [@B65]). However, it is unclear whether this regulation is mediated by Cdk5 or not.

Downstream Factors of p27: Regulation of Cytoskeletal Organization
------------------------------------------------------------------

What are the underlying mechanisms of the EXCERF of p27? Accumulating evidence indicates that a major downstream pathway targeted by p27 in EXCERF is cytoskeletal regulation. It has been reported that p27 promotes cofilin-mediated actin reorganization in neurons ([@B32]; [Figure 1B](#F1){ref-type="fig"}). Cofilin severs actin filaments and enhances the depolymerization of actin filaments ([@B55]). Cofilin directly binds to actin filaments but the phosphorylation at Ser3 by LIM kinase decreases its actin-binding affinity ([@B54]; [@B2]; [@B82]). LIM kinase is activated by RhoA-Rho kinase/ROCK and Rac1-PAK1 pathways. p27 negatively regulates Ser3-phosphorylation of cofilin via the suppression of RhoA, rather than Rac1, in cortical immature neurons, resulting in the activation of cofilin ([@B32]). p27 can directly bind to RhoA to inhibit the interaction between RhoA and its activators in non-neuronal cells ([@B5]). However, the binding affinity of p27 for RhoA is low ([@B63]), implying that some upstream signals strengthen the binding of these proteins or that p27 indirectly suppresses RhoA activity in neurons. Interestingly, RSK1 is reported to phosphorylate Thr198 of p27, resulting in enhanced binding between p27 and RhoA ([@B40]).

The p27-RhoA-cofilin pathway is important for not only neuronal migration and morphological changes in the developing cerebral cortex but also the establishment of long-term memory in the adult brain. Cks1 knockout mice have increased p27 protein levels and decreased Ser3-phosphorylation of cofilin (that is, cofilin activity is abnormally increased), and impairment of learning and long-term memory ([@B39]). Cks1 is strongly expressed in the hippocampus and required for late-phase long-term potentiation (late LTP) and proper maturation of dendritic spines.

A recent report indicates that p27 binds to another actin-binding protein, Cortactin, in non-neuronal cells ([@B28]). p27 promotes the interaction between Cortactin and PAK1, and PAK1-mediated phosphorylation of Cortactin enhances the turnover of invadopodia. Thus, it is possible that in addition to cofilin, p27 may also regulate the actin-binding protein(s) in cortical neurons.

In the inhibitory neurons in the developing cerebral cortex, p27 interacts with microtubules and promotes its polymerization ([@B18]). Furthermore, p27 binds to ATAT1 to increase the acetylation of microtubules, as described above ([@B53]). Thus, p27 regulates multiple downstream events to control both actin and microtubule cytoskeletal organization ([Figure 1B](#F1){ref-type="fig"}).

Downstream Factors of p27: Possible Involvement in Membrane Trafficking
-----------------------------------------------------------------------

A major EXCERF of p27 is cytoskeletal organization. In addition to this, several reports suggest roles for p27 in membrane trafficking. In cultured cell lines, including NIH-3T3 and HeLa cells, p27 is colocalized with SNX6, a sorting nexin family protein that controls retrograde vesicular transport from early endosomes to *trans*-Golgi networks (TGNs), and LAMP2, a marker for lysosomes ([@B17]). Although p27 is generally degraded in proteasomes, a small fraction of p27 may undergo lysosomal degradation when cells reenter the cell cycle in response to serum stimulation ([@B17]). Furthermore, p27 is reported to interact with p27RF-Rho/p18/LAMTOR1 (hereafter, LAMTOR1), which is localized in late endosomes and lysosomes ([@B22]; [@B21]; [@B76]). However, our high-resolution microscopy analyses revealed no colocalization of p27 with SNX6 or LAMTOR1 in primary cortical neurons ([Figure 2A,B,K](#F2){ref-type="fig"}), although some localization of p27 and LAMTOR1 is observed together in the same vesicular components ([Figure 2B](#F2){ref-type="fig"}). In addition, inhibition of lysosomal degradation pathways by knockdown of Rab7 did not significantly affect the protein levels of p27 in cortical neurons ([Figure 2C,D](#F2){ref-type="fig"}).

![Subcellular localization of p27. **(A,B,E--K)** Primary cortical neurons from E15 cerebral cortices incubated for 2 days *in vitro* and stained with the indicated antibodies. Immunocytochemical analyses were performed as described previously ([@B71]). Fluorescence images were obtained by A1R laser scanning confocal microscopy with a high sensitivity GaAsP detector (Nikon) using the narrow pinhole size (0.3) and subjected to deconvolution processing with the Richardson-Lucy algorithm in NIS-ER software (Nikon). The graph in **(K)** shows the colocalization efficient (Pearson's correlation) of the indicated proteins with p27, as determined using NIS elements software (Nikon). Significance was determined by Kruskal-Wallis test with post hoc Steel-Dwass test \[\< the critical value at 1% (Rab6 vs. SNX6 or LAMTOR1 or Rab5 or Rab7 or Rab8 or Rab11 or β-tubulin; p115 vs. SNX6 or LAMTOR1 or Rab5 or Rab7 or Rab8 or Rab11 or β-tubulin; GM130 vs. SNX6 or LAMTOR1 or Rab5 or Rab7 or Rab8 or Rab11 or β-tubulin. Dcx vs. SNX6 or LAMTOR1 or Rab5 or Rab7 or Rab8 or Rab11 or β-tubulin; Rab5 vs. LAMTOR1 or Rab7; LAMTOR1 vs. Rab8 or Rab11 or β-tubulin)\]. **(C,D)** Primary cortical neurons from E15 cerebral cortices transfected with control vector or shRNA-expressing vector targeting for Rab7 (Rab7-sh108 ([@B33])) plus pCAG-EGFP ([@B31]) and incubated for 2 days *in vitro*. Immunoblot analyses were performed as described previously ([@B32]). The graph in **(D)** shows the ratios of immunoblot band intensities of p27/β-actin ± s.e.m. (*n* = 6). No significant differences (n.s.) between control and Rab7-sh108-transfected neurons were found by Student's *t*-test (*P* = 0.3232). Primary antibodies used in this figure were anti-p27 (610241, BD Biosciences) (green in **A,B,E,F,J**, and immunoblots in **C,D**), anti-p27 (3686, Cell Signaling Technology) (red in **G--I**), anti-SNX6 (PA5-61948, Thermo Fisher Scientific), anti-LAMTOR1 (8975, Cell Signaling Technology), anti-Rab5 (3547, Cell Signaling Technology), anti-Rab6 (9625, Cell Signaling Technology), anti-Rab7 (9367, Cell Signaling Technology), anti-Rab8 (6975, Cell Signaling Technology), anti-Rab11 (5589, Cell Signaling Technology), anti-GM130 (610822, BD Biosciences), anti-p115 (612260, BD Biosciences), anti-β-tubulin (T5201, Sigma), anti-Dcx (4604, Cell Signaling Technology) and anti-β-actin (A5441, Sigma) antibodies. Scale bars: 4 μm in (**E** and upper panels in **A,B,F**), 1 μm in (lower panels in **A,B**, middle and lower panels in **F**), 1 μm in **(G--J)**.](fcell-07-00064-g002){#F2}

Given that the degradation of p27 is not dependent on lysosomes, we examined the possible association of p27 with other endosomal pathways. Rab5, Rab7, and Rab11, markers for early, late and recycling endosomes, respectively, are known to regulate cortical neuronal migration, similar to p27 ([@B33]; [@B29]). However, we observed little to no colocalization between p27 and these Rab proteins in primary cortical neurons ([Figure 2E,K](#F2){ref-type="fig"}). A similar result was found with Rab8, a regulator of secretion pathways ([@B20]; [@B72]; [Figure 2E,K](#F2){ref-type="fig"}), indicating low association of p27 with endosomal and Rab8-dependent pathways. In contrast, a small percentage of Rab6, a marker for Golgi, seems to be associated with p27. High-resolution microscopy analyses revealed that some p27 associates with Rab6-positive compartments ([Figure 2F,K](#F2){ref-type="fig"}). In addition, a small percentage of p27 is observed at the tubular compartments positive for GM130 or p115, markers for Golgi apparatus ([Figure 2G,H,K](#F2){ref-type="fig"}). These data suggest that p27 may preferentially associate with Golgi apparatus in cortical neurons.

It is unclear whether p27 is associated with the Golgi membrane or not. Considering that p27 binds to microtubules and its associated proteins, stathmin and ATAT1, and regulates axonal transports ([@B3]; [@B18]; [@B53]), it is possible that p27 regulates microtubule-associated motor proteins to control the intracellular transport of the Golgi and other endosomes/organelles. In fact, some p27-positive puncta were observed along the microtubules ([Figure 2I](#F2){ref-type="fig"}). Furthermore, p27 partially colocalizes with Dcx, a microtubule-regulatory protein that is associated with human X-linked lissencephaly ([Figure 2J,K](#F2){ref-type="fig"}).

Interestingly, knockout of p27 enhances the trafficking of CTxB, a marker for GM1 ganglioside-positive lipid rafts, in cultured fibroblasts possibly due to altered stathmin-mediated regulation of microtubule stability ([@B4]), suggesting that p27 negatively regulates lipid raft-mediated endocytosis. In cortical neurons, CTxB is internalized via caveolin-1-mediated endocytosis at least in part ([@B71]). In addition, a recent report indicates that caveolin-1 enhances the elimination of the immature neurites in cortical neurons ([@B71]), which is opposite to the effect of p27 that promotes immature neurite formation ([@B32]). Thus, the observation of p27-mediated microtubule regulation in lipid raft trafficking in non-neuronal cells may be consistent with *in vivo* function of p27 and caveolin-1 in immature neurons in the developing cerebral cortex.

Conclusion and Future Direction
===============================

In this paper, we introduce the EXCERF of p27, such as cytoskeletal organization and membrane trafficking. Other cell cycle-related proteins also exhibit EXCERF ([@B16]; [@B34]). For example, p21 and p57 are known to regulate neurite extension and neuronal migration, respectively ([@B77]; [@B25]). E2F3, a transcription factor that is negatively controlled by Rb, is also reported to control neuronal migration ([@B50]). Cdh1-Anaphase promoting complex (APC) and Cdc20-APC, both of which are E3 ubiquitin ligases, regulate axonal growth and dendrite morphogenesis ([@B37]; [@B35]). Furthermore, cyclin E regulates synapse number and synaptic plasticity through the restraining of Cdk5 activity ([@B59]). Thus, many cell cycle-related proteins have functions in G0-arrested neurons ([Figure 1C](#F1){ref-type="fig"}).

Alternatively, expression of other cell cycle-related proteins is suppressed during cell cycle exit. Re-expression of these cell cycle-related proteins, including cyclin A and PCNA, activates cell cycle events in post-mitotic neurons, and leads to cell death and neurodegenerative diseases ([@B83]; [Figure 1C](#F1){ref-type="fig"}). Consistently, knockdown of p27 in post-mitotic supporting cells in postnatal cochleae induces cell cycle re-entry, but these cells eventually undergo apoptosis ([@B60]).

Thus, we could classify cell cycle-related proteins into two categories ([Figure 1C](#F1){ref-type="fig"}). One set exhibits EXCERF even in G0-arrested cells, such as post-mitotic neurons. The other set is normally suppressed soon after growth arrest and their re-activation is a trigger to cell death. Growth arrest may be an important signal that activates the EXCERF of the former group of proteins, including p27, p57, APC, and cyclin E, and silences proteins in the latter group. This concept raises many questions to be solved. What happens at the timing of growth arrest? What are the differences between cell cycle proteins with or without EXCERF? What are the global picture and regulatory mechanisms of EXCERF? More specifically, what are the physiological roles of the puncta-like cytoplasmic p27? Future studies will answer these fundamental questions and will consolidate this new concept of EXCERF in cell biology and neuroscience.
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